$143 Million is the total value of Burrage Capital Management LLC's 26 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 35.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EPZM | Sell | EPIZYME INC COM | $14,314,000 | +14.2% | 891,277 | -0.3% | 10.02% | -18.8% |
| MEIP | Sell | MEI PHARMA INC COM NEW | $12,395,000 | +177.5% | 3,001,150 | -0.6% | 8.67% | +97.3% |
| PTCT | Sell | PTC THERAPEUTICS INC COM | $9,102,000 | +11.6% | 179,386 | -1.0% | 6.37% | -20.6% |
| GTHX | Sell | G1 THERAPEUTICS INC COM | $9,070,000 | +132.9% | 373,876 | -1.1% | 6.35% | +65.6% |
| ISEE | Sell | IVERIC BIO INC COM | $7,532,000 | +50.9% | 1,476,871 | -2.9% | 5.27% | +7.3% |
| KIDS | Sell | ORTHOPEDIATRICS CORP COM | $7,416,000 | +11.1% | 169,468 | -1.0% | 5.19% | -21.0% |
| ANAB | Sell | ANAPTYSBIO INC COM | $7,330,000 | +63.6% | 328,114 | -1.1% | 5.13% | +16.3% |
| ADCT | New | ADC THERAPEUTICS SA SHS ISIN#CH0499880968 | $6,315,000 | – | 134,912 | +100.0% | 4.42% | – |
| CYTK | Sell | CYTOKINETICS INC COM NEW | $6,163,000 | +70.5% | 261,491 | -17.8% | 4.31% | +21.3% |
| NEO | Sell | NEOGENOMICS INC COM NEW | $5,893,000 | +12.5% | 190,205 | -1.1% | 4.12% | -20.0% |
| AIMT | Buy | AIMMUNE THERAPEUTICS INC COM | $5,557,000 | +245.4% | 332,546 | +195.5% | 3.89% | +145.5% |
| FULC | New | FULCRUM THERAPEUTICS INC COM | $5,334,000 | – | 291,645 | +100.0% | 3.73% | – |
| YMAB | Sell | Y-MABS THERAPEUTICS INC COM | $5,315,000 | +20.4% | 123,025 | -28.4% | 3.72% | -14.3% |
| TPTX | TURNING PT THERAPEUTICS INC COM | $4,985,000 | +53.4% | 77,172 | 0.0% | 3.49% | +9.1% | |
| FREQ | Buy | FREQUENCY THERAPEUTICS INC COM | $4,741,000 | +57.6% | 203,917 | +17.2% | 3.32% | +12.1% |
| INSM | Buy | INSMED INC COM PAR 01 | $4,555,000 | +352.3% | 165,400 | +152.9% | 3.19% | +221.7% |
| RGNX | REGENXBIO INC COM | $4,235,000 | +19.7% | 115,000 | 0.0% | 2.96% | -14.9% | |
| AUPH | Buy | AURINIA PHARMACEUTICALS INC COM ISIN#CA05156V1022 | $4,167,000 | +43.6% | 256,438 | +30.5% | 2.92% | +2.1% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS INC COM | $4,142,000 | +3.0% | 236,394 | -16.3% | 2.90% | -26.8% |
| AVRO | AVROBIO INC COM | $3,942,000 | +20.4% | 225,900 | 0.0% | 2.76% | -14.3% | |
| ADVM | ADVERUM BIOTECHNOLOGIES INC COM | $3,258,000 | +109.0% | 156,012 | 0.0% | 2.28% | +48.6% | |
| APLS | APELLIS PHARMACEUTICALS INC COM | $2,432,000 | +19.3% | 74,452 | 0.0% | 1.70% | -15.2% | |
| MRUS | New | MERUS B V COM ISIN#NL0011606264 | $2,255,000 | – | 140,176 | +100.0% | 1.58% | – |
| ZGNX | ZOGENIX INC COM NEW | $1,891,000 | +14.5% | 70,000 | 0.0% | 1.32% | -18.6% | |
| ADRO | ADURO BIOTECH INC COM | $314,000 | -13.5% | 135,898 | 0.0% | 0.22% | -38.4% | |
| AUTL | AUTOLUS THERAPEUTICS LTD SPONSORED ADSspon ads | $241,000 | +186.9% | 15,006 | 0.0% | 0.17% | +103.6% | |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -682,586 | -100.0% | -0.28% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -56,699 | -100.0% | -0.55% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -115,899 | -100.0% | -1.15% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -88,445 | -100.0% | -1.17% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -200,000 | -100.0% | -2.08% | – |
| TCDA | Exit | TRICIDA INC | $0 | – | -131,661 | -100.0% | -2.74% | – |
| CARA | Exit | CARA THERAPEUTICS INC | $0 | – | -258,766 | -100.0% | -3.24% | – |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -482,982 | -100.0% | -3.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EPIZYME INC COM | 7 | Q2 2021 | 15.9% |
| NeoGenomics Inc | 7 | Q2 2021 | 8.7% |
| OrthoPediatrics Corp | 7 | Q2 2021 | 7.3% |
| Y-MABS THERAPEUTICS INC COM | 7 | Q2 2021 | 4.3% |
| CRINETICS PHARMACEUTICALS INC COM | 7 | Q2 2021 | 5.6% |
| G1 THERAPEUTICS INC COM | 7 | Q2 2021 | 7.3% |
| PTC THERAPEUTICS INC COM | 6 | Q1 2021 | 8.0% |
| CYTOKINETICS INC COM NEW | 6 | Q2 2021 | 4.9% |
| TURNING PT THERAPEUTICS INC COM | 6 | Q2 2021 | 6.7% |
| APELLIS PHARMACEUTICALS INC COM | 6 | Q1 2021 | 3.5% |
View Burrage Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Protalix BioTherapeutics, Inc.Sold out | July 30, 2021 | 0 | 0.0% |
| IVERIC bio, Inc. | February 14, 2020 | 10 | 3.4% |
View Burrage Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| SC 13G/A | 2021-07-30 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-12 |
| SC 13G | 2021-02-12 |
| 13F-HR | 2020-11-13 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-14 |
View Burrage Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.